Sign up
Log in
Reliance Global Q1 FY26 net loss narrows to $1.4 million; commission income falls to $3.8 million
Share
Listen to the news
Reliance Global Q1 FY26 net loss narrows to $1.4 million; commission income falls to $3.8 million
  • Reliance Global Group posted a net loss of $1.4 million for first-quarter 2026, narrowing from $1.7 million a year earlier.
  • Commission income slipped to $3.8 million from $4.2 million, reflecting 2025 divestitures of non-core operations; retained businesses delivered 11% organic revenue growth.
  • Unrestricted cash climbed 73% to $2.3 million, while working capital increased 39% to $2.6 million.
  • Expanded investment in post-quantum cybersecurity platform Enquantum, lifting ownership to about 29% as it advances a pathway toward potential majority control.
  • Launched LifeSci Global Group, investing in Innervate Radiopharmaceuticals as part of Scale51 push into technology and life sciences alongside insurance and InsurTech operations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reliance Global Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605071608PRIMZONEFULLFEED9715975) on May 07, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.